A commentary on 'Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab plus chemotherapy for early-stage triple-negative breast cancer: an experimental single-arm phase II clinical trial pilot study'.

Details

Language :

English

ISSN :

17439191

Volume :

110

Issue :

6

Database :

Supplemental Index

Journal :

International Journal of Surgery

Publication Type :

Academic Journal

Accession number :

179864648

Full Text :

https://doi.org/10.1097/JS9.0000000000001253